Literature DB >> 26923284

Musculoskeletal manifestations of the antiphospholipid syndrome.

M H A Noureldine1, M A Khamashta2, M Merashli3, T Sabbouh1, G R V Hughes4, I Uthman5.   

Abstract

The scope of clinical and laboratory manifestations of the antiphospholipid syndrome (APS) has increased dramatically since its discovery in 1983, where any organ system can be involved. Musculoskeletal complications are consistently reported in APS patients, not only causing morbidity and mortality, but also affecting their quality of life. We reviewed all English papers on APS involvement in the musculoskeletal system using Google Scholar and Pubmed; all reports are summarized in a table in this review. The spectrum of manifestations includes arthralgia/arthritis, avascular necrosis of bone, bone marrow necrosis, complex regional pain syndrome type-1, muscle infarction, non-traumatic fractures, and osteoporosis. Some of these manifestations were reported in good quality studies, some of which showed an association between aPL-positivity and the occurrence of these manifestations, while others were merely described in case reports.
© The Author(s) 2016.

Entities:  

Keywords:  Antiphospholipid syndrome; antibodies; arthralgia; arthritis; avascular necrosis; bone marrow necrosis; complex regional pain syndrome; muscle infarction; non-traumatic fractures; osteoporosis

Mesh:

Substances:

Year:  2016        PMID: 26923284     DOI: 10.1177/0961203316636467

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

Review 1.  Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Authors:  Mohammad Hassan A Noureldine; Ali A Haydar; Ahmad Berjawi; Rody Elnawar; Ahmad Sweid; Munther A Khamashta; Graham R V Hughes; Imad Uthman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 2.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

3.  Secondary Erosive Arthritis in a Young Lady - A Rare Manifestation of Primary Antiphospholipid Antibody Syndrome.

Authors:  Sathish Muthu; Girinivasan Chellamuthu; Thiruvenkita Prasad Gopalsamy; Velmurugan Kandasamy
Journal:  J Orthop Case Rep       Date:  2021-02

4.  Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study.

Authors:  Neslihan Gokcen; Andac Komac; Fatma Tuncer; Gizem Kocak Buyuksutcu; Ozlem Ozdemir Isik; Ayten Yazici; Ayse Cefle
Journal:  Rheumatol Int       Date:  2021-06-06       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.